Chapter 16: Regulation of Gene Expression in Eukaryotes

Eukaryotic gene regulation represents a complex multi-layered system that allows cells to generate diverse phenotypes from a single genome through mechanisms operating at transcriptional, post-transcriptional, translational, and post-translational levels. Unlike prokaryotes where transcription and translation occur simultaneously, eukaryotic cells spatially and temporally separate these processes, enabling sophisticated control over when, where, and how much gene product is made. At the chromatin level, genes exist in condensed, transcriptionally silent states that must be remodeled into accessible configurations through histone acetylation by histone acetyltransferase complexes and nucleosome repositioning by chromatin remodeling machinery. Cis-acting regulatory sequences including promoters, enhancers, and silencers recruit specific transcription factors that function as activators or repressors, often acting over long distances through three-dimensional DNA looping to establish enhanceosomes that fine-tune expression levels. Post-transcriptional regulation adds another layer of complexity through alternative splicing, wherein a single gene produces multiple protein variants, exemplified by genes like Dscam in Drosophila that can generate tens of thousands of distinct proteins. RNA-binding proteins orchestrate splicing patterns and control mRNA stability through mechanisms including deadenylation, decapping, and nonsense-mediated decay that eliminate defective transcripts. Small regulatory RNAs including microRNAs and small interfering RNAs silence target mRNAs through RNA interference pathways involving the RISC complex, while long noncoding RNAs function as molecular scaffolds or competing endogenous RNAs that sequester miRNAs away from their targets. mRNA localization ensures proteins are synthesized in appropriate cellular compartments, with zinc-binding proteins directing actin mRNA to filopodia in migrating cells. Post-translational modifications including phosphorylation and ubiquitination determine protein activity and stability, with ubiquitin-mediated proteasomal degradation affecting over forty percent of the human proteome. This hierarchical regulatory architecture enables dynamic adjustment of gene expression across developmental stages, environmental conditions, and cellular contexts, providing the molecular foundation for understanding development, differentiation, and disease pathogenesis including cancer progression.